Lynch syndrome and sextuple primary malignancies

References

• Hampel H, Frankel WL, Martin E, et al. Feasibility of screening for Lynch syndrome among patients with colorectal cancer. J Clin Oncol. 2008;26:5783–5788.
   PubMed Web of Science ®Google Scholar
• Lynch HT, Chapelle A. d l. Genetic susceptibility to non-polyposis colorectal cancer. J Med Genet. 1999;36:801–818.
   PubMed Web of Science ®Google Scholar
• Umar A, Boland CR, Terdiman JP, et al. Revised bethesda guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J Natl Cancer Inst. 2004;96:261–268.
   PubMed Web of Science ®Google Scholar
• Win AK, Lindor NM, Young JP, et al. Risks of primary extracolonic cancers following colorectal cancer in Lynch syndrome. J Natl Cancer Inst. 2012;104:1363–1372.
   PubMedGoogle Scholar
• Lin KM, Shashidharan M, Ternent CA, et al. Colorectal and extracolonic cancer variations in MLH1/MSH2 hereditary nonpolyposis colorectal cancer kindreds and the general population. Dis Colon Rectum. 1998;2:428–433.
   Google Scholar
• Peltomäki P. DNA mismatch repair gene mutations in human cancer. Environ Health Perspect. 1997;105:775–780.
   PubMed Web of Science ®Google Scholar
• Palomaki GE, McClain MR, Melillo S, et al. EGAPP supplementary evidence review: DNA testing strategies aimed at reducing morbidity and mortality from Lynch syndrome. Genet Med. 2009;11:42–65.
   PubMed Web of Science ®Google Scholar
• Watson P, Vasen HF, Mecklin JP, et al. The risk of extra-colonic, extra-endometrial cancer in the Lynch syndrome. Int J Cancer. 2008;123:444–449.
   PubMed Web of Science ®Google Scholar
• Dowty JG, Win AK, Buchanan DD, et al. Cancer risks for MLH1 and MSH2 mutation carriers. Hum Mutat. 2013;34:490–497.
   PubMed Web of Science ®Google Scholar
• Lynch HT, Lynch PM, Lanspa SJ, et al. Review of the Lynch syndrome: history, molecular genetics, screening, differential diagnosis, and medicolegal ramifications. Clin Genet. 2009;76:1–18.
   PubMed Web of Science ®Google Scholar
• Vasen HF, Blanco I, Aktan-Collan K, et al. Revised guidelines for the clinical management of Lynch syndrome (HNPCC): recommendations by a group of European experts. Gut. 2013;62:812–823.
   PubMed Web of Science ®Google Scholar
• Lindgren G, Liljegren A, Jaramillo E, et al. Adenoma prevalence and cancer risk in familial non-polyposis colorectal cancer. Gut. 2002;50:228–234.
   PubMed Web of Science ®Google Scholar
• Sankila R, Aaltonen LA, Järvinen HJ, et al. Better survival rates in patients with MLH1-associated hereditary colorectal cancer. Gastroenterology. 1996;110:682–687.
   PubMed Web of Science ®Google Scholar
• Stigliano V, Assisi D, Cosimelli M, et al. Survival of hereditary non-polyposis colorectal cancer patients compared with sporadic colorectal cancer patients. J Exp Clin Cancer Res. 2008;27:39.
   PubMed Web of Science ®Google Scholar
• Haghighi MM, Vahedi M, Mohebbi SR, et al. Comparison of survival between patients with hereditary non polyposis colorectal cancer (HNPCC) and sporadic colorectal cancer. Asian Pac J Cancer Prev. 2009;10:209–212.
   PubMedGoogle Scholar
• Singh H, Schiesser R, Anand G, et al. Underdiagnosis of Lynch syndrome involves more than family history criteria. Clin Gastroenterol Hepatol. 2010;8:523–529.
   PubMed Web of Science ®Google Scholar
• Mvundura M, Grosse SD, Hampel H, et al. The cost-effectiveness of genetic testing strategies for Lynch syndrome among newly diagnosed patients with colorectal cancer. Genet Med. 2010;12:93–104.
   PubMed Web of Science ®Google Scholar
• Németh Z, Czigner J, Iván L, et al. Quadruple cancer, including triple cancers in the head and neck region. Neoplasma. 2002;49:412–414.
   PubMed Web of Science ®Google Scholar
• Haselkorn T, Whittemore AS, Lilienfeld DE. Incidence of small bowel cancer in the United States and worldwide: geographic, temporal, and racial differences. Cancer Causes Control. 2005;16:781–787.
   PubMed Web of Science ®Google Scholar
• Hatzaras I, Palesty JA, Abir F, et al. Small-bowel tumors: epidemiologic and clinical characteristics of 1260 cases from the connecticut tumor registry. Arch Surg. 2007;142:229–235.
   PubMed Web of Science ®Google Scholar
• Lepage C, Bouvier A-M, Manfredi S, et al. Incidence and management of primary malignant small bowel cancers: a well-defined French population study. Am J Gastroenterol. 2006;101:2826–2832.
   PubMed Web of Science ®Google Scholar
• Kate G. L t, Kleibeuker JH, Nagengast FM, et al. Is surveillance of the small bowel indicated for Lynch syndrome families? Gut. 2007;56:1198–1201.
   PubMed Web of Science ®Google Scholar
• Parc Y, Boisson C, Thomas G, et al. Cancer risk in 348 French MSH2 or MLH1 gene carriers. J Med Genet. 2003;40:208–213.
   PubMed Web of Science ®Google Scholar
• Parry S, Win AK, Parry B, et al. Metachronous colorectal cancer risk for mismatch repair gene mutation carriers: the advantage of more extensive colon surgery. Gut. 2011;60:950–957.
   Web of Science ®Google Scholar
• de Vos tot Nederveen Cappel WH, Buskens E, van Duijvendijk P, et al. Decision analysis in the surgical treatment of colorectal cancer due to a mismatch repair gene defect. Gut. 2003;52:1752–1755.
   PubMed Web of Science ®Google Scholar
• Vasen HFA, Möslein G, Alonso A, et al. Guidelines for the clinical management of Lynch syndrome (hereditary non-polyposis cancer). J Med Genet. 2007;44:353–362.
   PubMed Web of Science ®Google Scholar
• Zhao J, Tan Y, Wu Y, et al. A rare case of eight multiple primary malignant neoplasms in a female patient: a case report and review of the literature. Oncol Lett. 2015;9:587–590.
   PubMed Web of Science ®Google Scholar
• Pedroni M, Di Gregorio C, Cortesi L, et al. Double heterozygosity for BRCA1 and hMLH1 gene mutations in a 46-year-old woman with five primary tumors. Tech Coloproctol. 2014;18:285–289.
   PubMed Web of Science ®Google Scholar
• Mehboob R, Asma M, Bukhari MH. Lynch syndrome presenting a wide spectrum of tumors-a case report. Kemcolian J Med Sci. 2012;1. https://www.researchgate.net/publication/256457211.
   Google Scholar
• Hu N-C, Hsieh S-C, Chen T-J, et al. Multiple primary malignancies including colon, stomach, lung, breast, and liver cancer: a case report and literature review. Chin Med J. 2009;122:3091–3093.
   PubMed Web of Science ®Google Scholar
• Noh S-K, Yoon JY, Ryoo UN, et al. A case report of quadruple cancer in a single patient including the breast, rectum, ovary, and endometrium. J Gynecol Oncol. 2008;19:265–269.
   PubMedGoogle Scholar
• Gnanalingham KK, Hall CN, Bishop P. Synchronous and metachronous gastric adenocarcinoma: case report and literature review. J R Coll Surg Edinb. 1999;44:61–62.
   PubMedGoogle Scholar